Study to Evaluate IV CR845 in Hemodialysis Patients With Moderate-to-Severe Pruritus
Clinical trial NCT02858726 · COMPLETED
Trial details
- NCT number
- NCT02858726
- Sponsor
- Cara Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-06-01
- Primary completion
- 2017-03-14
- Enrollment
- 226
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.